Can you provide the average price target for TRANSUNION stock?
25 analysts have analysed TRU and the average price target is 94.65 USD. This implies a price increase of 24.87% is expected in the next year compared to the current price of 75.795.
NYSE:TRU • US89400J1079
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TRANSUNION (TRU).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-16 | Mizuho | Initiate | Neutral |
| 2026-04-13 | UBS | Maintains | Neutral -> Neutral |
| 2026-03-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-02-17 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2026-02-13 | Needham | Maintains | Buy -> Buy |
| 2026-02-13 | Stifel | Maintains | Buy -> Buy |
| 2026-02-13 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-10-24 | Needham | Reiterate | Buy -> Buy |
| 2025-10-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-24 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-10-02 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-10-01 | Seaport Global | Initiate | Neutral |
| 2025-09-03 | Needham | Upgrade | Hold -> Buy |
| 2025-07-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-07-25 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-25 | Needham | Reiterate | Hold -> Hold |
| 2025-07-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-10 | BMO Capital | Initiate | Outperform |
| 2025-07-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-22 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-25 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.831B 3.27% | 4.184B 9.20% | 4.576B 9.38% | 5.086B 11.14% | 5.495B 8.04% | 5.927B 7.86% | 6.258B 5.58% | 6.739B 7.69% | |
| EBITDA YoY % growth | 1.145B -0.43% | 1.271B 11.08% | 1.439B 13.22% | 1.808B 25.61% | 2.003B 10.79% | 2.207B 10.18% | 2.36B 6.93% | 2.563B 8.60% | |
| EBIT YoY % growth | 620.1M -1.65% | 733.5M 18.29% | 864.6M 17.87% | 1.047B 21.10% | 1.319B 25.98% | 1.618B 22.67% | N/A | N/A | |
| Operating Margin | 16.19% | 17.53% | 18.89% | 20.59% | 24.00% | 27.30% | N/A | N/A | |
| EPS YoY % growth | 3.37 -6.91% | 3.92 16.32% | 4.30 9.69% | 4.78 11.13% | 5.56 16.43% | 6.54 17.51% | 7.64 16.87% | 8.70 13.88% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.11 5.28% | 1.18 9.51% | 1.25 14.00% | 1.24 15.75% | 1.28 15.95% | 1.36 14.73% | 1.44 14.95% | 1.41 14.00% | 1.49 16.10% | 1.55 13.88% | 1.64 13.75% | 1.60 13.03% |
| Revenue Q2Q % growth | 1.22B 11.34% | 1.261B 10.64% | 1.294B 10.65% | 1.287B 9.87% | 1.32B 8.20% | 1.356B 7.53% | 1.401B 8.27% | 1.386B 7.69% | 1.404B 6.36% | 1.438B 6.05% | 1.478B 5.50% | 1.464B 5.63% |
| EBITDA Q2Q % growth | 425.63M 8.22% | 445.93M -5.88% | 467.8M -26.89% | 462.24M -40.75% | 474.15M 11.40% | 495.08M 11.02% | 516.01M 10.31% | 505.76M 9.42% | 514.79M 8.57% | 534.17M 7.90% | 558.96M 8.32% | 547.42M 8.24% |
| EBIT Q2Q % growth | 260.36M 2.34% | 272.19M 41.62% | 294.78M 38.59% | 288.92M 40.73% | 294.72M 13.20% | 306.07M 12.45% | 326.54M 10.77% | 317.14M 9.77% | 367.49M 24.69% | 383.18M 25.19% | 403.98M 23.72% | 391.69M 23.51% |
All data in USD
25 analysts have analysed TRU and the average price target is 94.65 USD. This implies a price increase of 24.87% is expected in the next year compared to the current price of 75.795.
TRANSUNION (TRU) will report earnings on 2026-04-28, before the market open.
The consensus EPS estimate for the next earnings of TRANSUNION (TRU) is 1.11 USD and the consensus revenue estimate is 1.22B USD.
The consensus rating for TRANSUNION (TRU) is 81.6 / 100 . This indicates that analysts generally have a positive outlook on the stock.